Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Male Infertility Market to Experience Robust Growth due to Acceptance of Assisted Reproductive Technologies Till 2025 | Million Insights


News provided by

Million Insights

13 May, 2019, 10:40 GMT

Share this article

Share toX

Share this article

Share toX

FELTON, California, May 13, 2019 /PRNewswire/ --The global Male Infertility Market is estimated to touch US$ 4.7 billion by the completion of the prediction period. The market was appreciated by US$ 301billion in the year 2016. Growing percentage of infertility all over the world and acceptance of Assisted Reproductive Technologies [ART] are likely to be important issues motivating the progress of the market.

Growing demand for Assisted Reproductive Technologies [ART] is the most important reason for the increasing income concerning male infertility all over the world. Assisted Reproductive Technologies [ART] offer support to males suffering from abnormal sperm counts, sperms with poor motility or no sperms. What's more, greater percentage of accomplishment related to medicine and progressions in expertise are likely to upsurge the demand in the near future. It motivates the progress of the market. The male infertility market is estimated to develop at a CAGR of 4.6% for the duration of the prediction.

The male infertility market on the source of Type of Treatment could span Medication, Assisted Reproductive Technology [ART]. The greatest select to treat an infertile male for a normal prenatal period is to improve spermatogenesis by hormonal treatment. The treatment is operative merely inpatient shaving small sperm computation.

Assisted Reproductive Technology [ART] is utilized to treat the most important male issues accountable for male infertility, for example trauma, chemotherapy, epididymal dysfunction, sperm autoantibodies, heat, accessory gland infection, viral orchitis, and further idiopathic issues. Greater price of treatment and necessity of sum of treatment rounds are the most important issues that support the creation of maximum income in the market.

Get Sample PDF and read more details about the "Male Infertility Market" Report 2025.

The male infertility industry on the source of Type of Test could span Sperm Penetration Assay, Sperm Agglutination, Oxidative Stress Analysis, Computer-Assisted Semen Analysis [CASA], Microscopic Examination, DNA Fragmentation Technique. The subdivision of "DNA fragmentation" is responsible for the prime section of the market. This could be credited to capability of test to deliver dependable investigation of sperm DNA reliability. Such as DNA fragmentation in sperm cells is a foremost reason of infertility in males, there is increasing acceptance of this test. This is expected to motivate the development of the market for the duration of the prediction.

Semen analysis is the greatest favored test and utilized by way of the most important test for analysis. In today's world, microscopic inspection and Computer-Assisted Semen Analysis [CASA] are used for semen analysis. Even though microscopic inspection held the largest share as equated to Computer-Assisted Semen Analysis [CASA] in the year 2016; it is likely to substitute the microscopic technique throughout the prediction period.

The subdivision of Oxidative Stress Test Analysis was the subsequent biggest subdivision by means of income in the year 2016 owing to increasing practice. Additional tests for analysis consist of sperm proteomics and sperm viability testing. The male infertility market on the source of Area with respect to Trades in terms of intake, Profits, Market stake and Development percentage in these areas, for the duration of the prediction could span North America [U.S.A, Canada], Europe [Germany, U.K.], Asia Pacific [Japan, China], Central & South America [Brazil, Mexico], Middle East & Africa [South Africa].

By the source of geography, Asia Pacific is likely to develop by a speedy percentage above the prediction period. Developing nations in the area, comprising Singapore, China and India have been facing robust financial development. Growing elderly inhabitants, increasing smoking, and the sicknesses related with the way of life, have caused in growing rate of male infertility in the area.

Europe ruled the market in 2016. It was responsible for above 30.0% stake of the entire market in the year 2016. Accessibility of well-furnished and progressive fertility treatment center, greater acceptance of expensive treatment, superior exposure for analysis& treatment, and greater consciousness stages are the aspects accountable for the supremacy of the area.

The statement revises Trades in terms of intake of Male Infertility in the market; particularly in North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. It concentrates on the topmost companies operating in these regions. Some of the important companies, operating in the field on the international basis are SCSA diagnostics, Inc., Halotech DNA SL, Cadila Healthcare Ltd., AytuBioScience Inc., Intas pharmaceuticals Ltd., EMD Sereno, Inc., Bayer Healthcare, and Andrology solutions.

Browse 100 page research report with TOC on "Global Male Infertility Market" at: https://www.millioninsights.com/industry-reports/male-infertility-market

Market Segment:

  • Male Infertility Test Outlook (Revenue, USD Million, 2014 - 2025)
      • DNA Fragmentation Technique
      • Oxidative Stress Analysis
      • Microscopic Examination
      • Sperm Agglutination
      • Computer Assisted Semen Analysis
      • Sperm Penetration Assay
      • Others
    • Male Infertility Treatment Outlook (Revenue, USD Million, 2014 - 2025)
      • Assisted Reproductive Technology
      • Medication
    • Male Infertility Regional Outlook (Revenue, USD Million, 2014 - 2025)
      • North America
        • U.S
        • Canada
      • Europe
        • U.K
        • Germany
      • Asia Pacific
        • Japan
        • China
      • Central & South America
        • Brazil
        • Mexico
      • Middle East & Africa
        • South Africa

Browse reports of similar category available with Million Insights:

  • Blood Screening Market
  • Newborn Screening Market
  • Teleradiology Market
  • Zika Virus Testing Market

About Million Insights:

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying, is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

Contact:
Ryan Manuel
Research Support Specialist, USA
Million Insights
Phone: +1-408-610-2300
Toll Free: 1-866-831-4085

Email: sales@millioninsights.com

Web: https://www.millioninsights.com/

Blog: https://millioninsights.blogspot.com/

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.